Australia explores use of vaccinia virus-based vaccines to fight monkeypox

New research suggests recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the m...

September 13, 2022 | Tuesday | News
Australia's Nutromics raises $14 M for ground-breaking wearable diagnostic platform

Australia-based medtech startup Nutromics has raised an additional $14 million for its wearable diagnostic platform...

September 12, 2022 | Monday | News
Australia designs molecule chip for modern manufacturing of drug, vaccines

Australia's University of Queensland (UQ) researchers have pioneered a new chemical process to manufacture the molecules...

September 8, 2022 | Thursday | News
Australia boosts availability of digitally enabled medical technologies

ANDHealth, Australia’s leading digital health commercialisation organisation, in partnership with the Victorian Go...

September 9, 2022 | Friday | News
Australian startup OccuRx secures $16 M to progress therapies for inflammation, fibrosis

Australian biotech startup OccuRx has announcesd a $16 million cash injection to progress into clinical phase studies fo...

September 7, 2022 | Wednesday | News
Global pandemic therapeutics centre to open in Australia

The establishment of the Cumming Global Centre for Pandemic Therapeutics has been announced by the University of Melbour...

September 5, 2022 | Monday | News
Monash University receives $10.8 M grants for COVID-19 research in Australia

Three Monash University projects have received $10.8 million from the Medical Research Future Fund (MRFF) to support res...

September 6, 2022 | Tuesday | News
Australia announces historic $478 M investment to change healthcare

The University of Sydney has announced its largest ever capital investment, a landmark $478 million to build a nation-...

September 2, 2022 | Friday | News
Swiss firm Helsinn Healthcare expands footprint in Asia and Middle East

Swiss firm Helsinn Group and Singapore's Juniper Biologics Pte Ltd, a science-led healthcare company focused on research...

September 2, 2022 | Friday | News
Dr Glenn Haifer and Ampersand Capital Partners acquire Australian biologics CDMO Luina Bio

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr Gle...

September 1, 2022 | Thursday | News
Australia develops AI model to help epilepsy patients become seizure-free

A study led by Monash University in Australia and believed to be a world first has demonstrated that an Artificial Intel...

September 1, 2022 | Thursday | News
Australia to focus research on five virus families likely to cause future pandemics

The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia's national science agency,...

August 30, 2022 | Tuesday | News
Pfizer emerges as leading company in Asia for COVID-19 response

Pfizer has been ranked first in its COVID-19 response, patient centricity, patient safety and bringing innovative, high-...

August 27, 2022 | Saturday | News
Some cancer immunotherapy treatments may damage fertility: Australian study

Researchers from Monash University, Australia have discovered that some immunotherapy treatments used to treat cancer ca...

August 29, 2022 | Monday | News
Australia cracks down on counterfeit drugs

The Therapeutic Goods Administration (TGA) led Australia's participation in INTERPOL's Operation Pangea, which tackles t...

August 26, 2022 | Friday | News
Australia opens first dedicated children's immunotherapy centre

Australia’s first dedicated children’s immunotherapy centre will investigate treatments to not only increase...

August 25, 2022 | Thursday | News
Alterity Therapeutics opens first site in Europe for drug trial of Multiple System Atrophy

Australia-based Alterity Therapeutics has announced that the company’s Phase 2 clinical trial of ATH434 for ...

August 25, 2022 | Thursday | News
Australia launches mobile service for mental healthcare

The Australian Government has announced the launch of the new Head to Health phone service which will help Aus...

August 23, 2022 | Tuesday | News
Hydrix receives approval for Guardian device in Singapore

Australia's Hydrix Limited has announced that the Health Services Authority of Singapore (HSA) has approved The Guardian...

August 23, 2022 | Tuesday | News
Long COVID-19 study in Australia identifies potential diagnostic and therapeutic targets

Australia-based Antisense Therapeutics has announced the outcomes from its collaboration to study the neurological aspec...

August 23, 2022 | Tuesday | News
Australia launches world-first preventative DNA screening for cancer, heart disease risk

The nationally collaborative project, led by Monash University and supported by researchers and clinicians across Austra...

August 22, 2022 | Monday | News
Australia invests $30 M to support vital brain and mental health research

Monash University has received a $30 million philanthropic gift that will fund vital mental health research and preventa...

August 19, 2022 | Friday | News
Australian startup Carina Biotech raises $7.5 M

Australia-based startup Carina Biotech has raised $7.5 million at first close of its current funding round, welcoming on...

August 18, 2022 | Thursday | News
EpiAxis Therapeutic, Peptilogics enter strategic drug discovery partnership

Australia's EpiAxis Therapeutics, a leading epigenetics company with a focus on the treatment, diagnosis and monitoring ...

August 17, 2022 | Wednesday | News
Moderna to build first mRNA production facility in Southern Hemisphere

Australia's Monash University has announced that US-based firm Moderna will be joining other world-leading research and ...

August 16, 2022 | Tuesday | News